Session Information
2011 Midyear Clinical Meeting
Click here to go to the previous page
Debates in Therapeutics 2011
Track:
Education Sessions (CE)
Program Code: 210-L01
Date: Monday, December 5, 2011
Time: 2:00 PM to 5:00 PM EST
Location:
Auditorium A, Mid Level
PRESENTER(S):
Julie Atay
Stuart Haines
Judith Jacobi
Julie Oestreich
Phillip Owen
Megan Rocchio
Rowena Schwartz
Robert Talbert, Professor Scott Vouri
PROGRAM CHAIR:
Kimberli Burgner
Description
Debate Topics:
• IV Immunoglobulin Dosing: Ideal vs Actual Body Weight
• Use of Activated Protein C in Sepsis
• Use of Pharmacogenomics Data with Clopidogrel
• Dabigatran vs Warfarin: Is It Cost Effective?
• IV Immunoglobulin Dosing: Ideal vs Actual Body Weight
• Use of Activated Protein C in Sepsis
• Use of Pharmacogenomics Data with Clopidogrel
• Dabigatran vs Warfarin: Is It Cost Effective?
- Compare the pro and con sides of selected therapeutic issues.
- Discuss why therapeutic controversy may occur.
- Identify four therapeutic areas in which controversy may exist.
This session is a part of:
This session is a part of: